Open an account

Amesite

AMST · NASDAQ

$0.7429−$0.0473 (−5.99%)TodayMarket closed ·
Prev close $0.7902

About AMST

Amesite, Inc. is a technology company, which engages in the development and marketing of B2C and B2B AI-driven solutions for the healthcare sector. The company is headquartered in Ann Arbor, Michigan and currently employs 6 full-time employees. The company went IPO on 2020-09-25. The firm focused on building and commercializing AI-powered solutions for the healthcare sector. The firm specializes in the development and marketing of business-to-consumer (B2C) and business-to-business (B2B) artificial intelligence (AI)-driven solutions, including its higher ed platform that offers professional learning. The firm's platform utilizes infrastructure to deliver both Amesite Engage for higher education and NurseMagic for healthcare. NurseMagic is a mobile app for healthcare professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations. NurseMagic is designed for use across various healthcare modalities, such as skilled nursing, assisted living, memory care, home health, and rehabilitation centers.

Employees
6
Headquarters
Ann Arbor, Michigan
Listed
Sep 25, 2020
Sector
Consumer Discretionary
Industry
Diversified Consumer Services
Website
amesite.com

AMST key statistics

Market cap
4.87M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
120.69K
Volume
27.97K
Open price
$0.8086
High today
$0.8086
Low today
$0.7429
52 Week high
$3.90
52 Week low
$0.77

Amesite (AMST) at a glance

Amesite (AMST) last traded at $0.7429, with a market cap of 4.87M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.7429 and $0.8086. The current price is 0.0% above the day's low and 8.1% below its high.

Volume so far is 27.97K shares, below the average of 120.69K shares a day.

Over the past year Amesite has ranged from $0.77 to $3.90, and now sits -1% of the way up that range.

Amesite met or beat analyst EPS estimates in 0 of the last 4 quarters. In Q2 FY26 it reported -$0.16 per share against an estimate of $0.00.

AMST earnings

Earnings per share, reported against the analyst estimate

Didn’t beat the estimate in any of the last 4 quarters.

  1. Q2 FY21: reported -$1.32 per share against an estimate of -$0.9792
  2. Q3 FY21: reported -$1.32 per share against an estimate of -$0.9792
  3. Q4 FY25: reported -$0.18 per share against an estimate of $0.00
  4. Q2 FY26: reported -$0.16 per share against an estimate of $0.00

AMST news

  • 12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session

  • 12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session

  • 12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session

  • Kaustubh Bagalkote

    Why Amesite Stock Is Surging On Wednesday?

  • 12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session

  • 12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session

  • Avi Kapoor

    Gold Falls 1%; Amer Sports Earnings Top Views

  • Dylan Berman

    Amesite Stock Soars Tuesday: Everything You Need To Know

Similar companies

Companies in the same industry as Amesite

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.